VHL and nonpapillary renal cell carcinoma: Liu et al. reported that VHL gene mutations affecting HIF1a binding (HM and TR) can increase the risk of developing ccRCC [16], furthermore, Gallou et al. found that mutations in the missense cluster regions were associated with an increased risk of RCC compared to those with missense mutations in other regions [17].